. 2014 Jan 15;6(2):367–380. doi: 10.4161/mabs.27830

Table 1. Overview of the human IgGs and RNases used in this study.

IgG	Antigen specificity	Remarks
MN	MN-antigen (tumor associated antigen carbonic anhydrase IX, CA9)	Integral plasma membrane glycoprotein
CTX	Cholera toxin (control antigen)	Soluble protein
Mesothelin	Mesothelin-antigen (tumor associated antigen; MSLN)	GPI-anchored plasma membrane glycoprotein
X	Undisclosed antigen X	GPI-anchored plasma membrane glycoprotein
RNase
RNase	Wild type human pancreatic RNase with truncated carboxy terminus (ΔSVEDST) for increased stability²⁶ according to reference 23
QBI-119	Wild type human pancreatic RNase with truncated carboxy terminus (ΔSVEDST) and with mutations providing RI evasion (R4C, G38R, R39D, L86E, N88R, G89D, R91D, V118C) according to patent WO2005115477
Jo2007	Wild type human pancreatic RNase with truncated carboxy terminus (ΔSVEDST) and with mutations providing RI evasion (R39D, N67D, N88A, G89D, R91D)²⁷

Abbreviations: GPI, glycophosphatidylinositol